TrialAmerican journal of respiratory and critical care medicine2025

Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance and Abnormal Glucose Metabolism: A Phase 3b, Open-Label Clinical Trial.

Isabelle Durieu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.